ArticleBioresources and bioprocessing2026
Physicochemical evaluation, GC-MS-based phytoconstituent analysis and network pharmacology study of Guduchi Arka: an ayurvedic hydro-distillate.
Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Guduchi Arka is a classical Ayurvedic hydro-distillate formulation with quick absorption and healing properties, prepared from Tinospora cordifolia (Willd.) Miers. Despite its long history of traditional use, the scientific community still lacks a complete set of quality parameters for its chemical composition and its molecular mechanisms. To overcome this problem, laboratory analysis and computer modelling parameters were used to investigate the quality, safety, and effectiveness of the formulation in treating fever and cold. Guduchi samples were obtained from three locations in India (Jhansi, Bengaluru, and Itanagar), and the raw materials were analysed to verify compliance with API standards. Authenticated Guduchi samples were processed arka preparation by using a standardised hydro-distillation method, and the resulting arka was assessed by physicochemical analysis, with a pH of 6.15-6.95, a specific gravity near 1.00, and an essential oil content of approximately 0.236%. Raw drugs and Arka preparations complied with standard API safety standards, as no pathogenic organisms were detected, heavy metals, pesticides, and aflatoxins were undetectable, and microbial content was below the standard API limit. GC-MS analysis of the arka formulation revealed a consistent and rich array of bioactive compounds, including 1-Eicosanol, α-Campholenal, o-toluric acid, Anethole, Estragole, Embelin, Nicolaioidesin A, (-)-Globulol, Paliclavine, and Chamazulene. To assess its therapeutic significance, 20 phytoconstituents of the Guduchi arka formulation were screened using network pharmacology and molecular docking. These compounds showed 248 overlapping targets with genes associated with fever and respiratory infections. The key regulatory proteins HSP90AA1, EGFR, and HSP90AB1 emerged as central nodes in the protein-protein interaction networks. To better validate the molecular docking study, robust biological interactions were observed: Nicolaiodesin A interacted effectively with EGFR (score: - 7.2 kcal/mol), whereas Embelin interacted effectively with HSP90AA1 (score: - 6.6 kcal/mol). Finally, this study demonstrates that Guduchi Arka is a highly standardised and safe formulation that retains all its healing phytochemicals during the distillation process. This study elucidates the mode of action of Guduchi Arka on immunity and inflammation, providing a solid scientific basis for its traditional use and future applications in herbal medicine.
Indexed as
Identifiers
42853356What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.